Navigation Links
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
Date:5/7/2009

ABBOTT PARK, Ill., May 7 /PRNewswire-FirstCall/ -- The Abbott RealTime HIV-1 Assay and Abbott m2000 System have been recommended as a standard protocol for viral load testing in HIV/AIDS clinical trials sponsored by the National Institutes of Health (NIH).

This recommendation was made by the Cross-Network Laboratory Focus Group (LFG), which consists of representatives from five of the NIH-sponsored HIV/AIDS clinical trials networks. The LFG recently issued a consensus statement, which was reviewed and approved by the leadership of the five networks, recommending the use of the Abbott RealTime HIV-1 assay and m2000 system for upcoming clinical trials in 2009 and beyond that have a primary focus on viral load measurements. The recommendation applies to testing performed at adult and pediatric therapeutic HIV/AIDS clinical trial sites both in the United States and internationally, as well as the centralized network laboratories in the United States.

Viral load testing is a monitoring tool used to determine the amount of virus in the blood and the efficacy of anti-HIV therapy. The growing prevalence of HIV-1 subtype variant and circulating recombinant strains has made accurate viral load detection more complex and has prompted increasing numbers of clinical laboratories to adopt the Abbott RealTime HIV-1 Assay on the m2000 System. The system is one of the fastest and most sensitive viral load tests available, with the ability to detect and precisely measure group M, N and O strains of HIV-1, as well as all known non-B subtypes.

"We're pleased that the LFG has recommended the Abbott RealTime HIV viral load assay to be the standard testing system for NIH-sponsored HIV/AIDS clinical trial networks," said Stafford O'Kelly, head of Abbott's molecular diagnostics business. "We look forward to supporting the NIH-sp
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
2. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
3. German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
4. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
5. Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees
6. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
7. NCPS Outraged at HIV/AIDS Medi-Cal Cuts
8. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
9. Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)...   Easy Breathe , the fastest growing online sleep ... " - has received more than 4.5 million unique page views ... thrilled that so many people are finding our blog and reading ... "We,re committed to making sleep apnea more widely known and hope ... sleep apnea news , troubleshooting advice , and ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 /PRNewswire/ ... new market research report is available in its ... Electronic Medical Records http://www.reportlinker.com/p0833392/EMR-2014-The-Market-for-Electronic-Medical-Records.html ... fast-changing market for electronic medical records (EMR) for ... a comprehensive report of our findings. Our report ...
(Date:8/20/2014)... 20, 2014 Phase I Trial ... US  KalVista Pharmaceuticals ("KalVista"), an ophthalmology company ... announces that it has begun a Phase I, First ... KVD001, for the treatment of DME. The study,s Principal ... Eye Institute, Joslin Diabetes Center; Harvard Medical School Department ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4EMR 2014: The Market for Electronic Medical Records 2EMR 2014: The Market for Electronic Medical Records 3EMR 2014: The Market for Electronic Medical Records 4EMR 2014: The Market for Electronic Medical Records 5EMR 2014: The Market for Electronic Medical Records 6EMR 2014: The Market for Electronic Medical Records 7EMR 2014: The Market for Electronic Medical Records 8KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... Galleon Pharmaceuticals, a leader in the pharmaceutical treatment of ... has elected Thomas J. Dietz, Ph.D., as the company,s ... Holdings, LLC, a diversified financial-holdings and services company.   ... then CEO and a director of Pacific Growth Equities, ...
... Reportlinker.com announces that a new market ... Medical Imaging Markets: Contrast ... The application and versatility of ... in significance as the population ages and ...
Cached Medicine Technology:Thomas Dietz, Ph.D., Elected Chairman of Galleon Pharmaceuticals 2Medical Imaging Markets: Contrast Agents 2Medical Imaging Markets: Contrast Agents 3Medical Imaging Markets: Contrast Agents 4Medical Imaging Markets: Contrast Agents 5Medical Imaging Markets: Contrast Agents 6
(Date:8/20/2014)... The Board of Directors of top ... is pleased to announce the expansion of its ... and the surrounding region. In support of this ... AIA has relocated to the firm’s office in Shanghai, ... and design and to better support regional clients. ...
(Date:8/20/2014)... the most persistent and deadliest infectious diseases in the ... , Scientists who study tuberculosis have long debated its ... humans in Africa to seals and sea lions that ... to Native people there before Europeans landed on the ... as a Source of New World Human Tuberculosis," was ...
(Date:8/20/2014)... through fast-moving waters may be at risk, suggests new ... salmon encounter turbulent, fast-moving water such as rapids ... upstream using a behaviour known as "burst swimming" that ... sockeye passed through extremely fast-moving water, we started to ... spawning grounds," said Nicholas Burnett, a research biologist at ...
(Date:8/20/2014)... 20, 2014 As concerns regarding the ... morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgery continue ... Senators from New York are urging the U.S. Food ... the devices. In a letter dated August 19th, Sens. ... the agency to seriously consider the testimony given during ...
(Date:8/20/2014)... NY (August 20, 2014) Research from Columbia University ... role in stomach cancer growth and that blocking nerve ... effective treatment for the disease. The study was conducted ... collaboration with Duan Chen, MD, PhD, in Norway and ... Medicine . , "Scientists have long observed that human ...
Breaking Medicine News(10 mins):Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3Health News:Salmon forced to 'sprint' less likely to survive migration 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Senators’ Letter Seeking FDA Morcellator Recall 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Senators’ Letter Seeking FDA Morcellator Recall 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Senators’ Letter Seeking FDA Morcellator Recall 4Health News:Severing nerves may shrink stomach cancers: Botox injections slow growth of tumors in mice 2
... with current devices , , MONDAY, Jan. 21 (HealthDay News) ... for overcoming the major problems with these tubes that ... Italian researchers report. , The new stent is not ... use, but with a special polymer designed to prevent ...
... in 2007, KNOXVILLE, Tenn., Jan. 21 ... clinical outsourcing, announced today,that it has initiated ... December 2007 and January 2008. These contracts ... medicine programs in seven,states., TeamHealth will ...
... WASHINGTON, Jan. 21 Senator Sam Brownback,and Rep. ... for Life, on,Tuesday, January 22, 2008. The conference ... College Professor Hadley P.,Arkes, Eric Scheidler, Michael Illions, ... live from Family Research Council,s headquarters., Senator ...
... DIEGO, Jan. 21 AMN Healthcare Services,Inc. (NYSE: ... United,States, will host its quarterly conference call to discuss ... 2008, at 5:00 p.m. Eastern,Time. The company expects to ... 2008 at approximately 4:00 p.m. Eastern Time., A ...
... Biosciences,(Nasdaq: MATK ) announced today that life,sDHA(TM), its ... heart health, is now available to,Australian consumers in Pocket ... is the largest juice and smoothie chain in the,Southern ... Pocket Rocket Juice provides,more than 100 percent of Australia,s ...
... kick butts, SAN DIEGO, Jan. 21 RealAge.com, ... a new program to guide and,support nicotine-free wannabes as ... Stop Smoking Center launched today. The center is packed,with ... MD, a,founder of RealAge and coauthor of YOU: Staying ...
Cached Medicine News:Health News:'Drug-Free' Stent Coating Shows Promise 2Health News:TeamHealth Announces Eight New Clinical Outsourcing Contracts 2Health News:Senator Sam Brownback and Rep. Chris Smith to Speak at Blogs for Life 2Health News:AMN Healthcare Services to Host 2007 Fourth Quarter & Year End Earnings Conference Call on Tuesday, February 26, 2008 2Health News:Pocket Rocket Juice from Australia's Boost Juice Features 700 mg of Martek's life'sDHA(TM) 2Health News:Pocket Rocket Juice from Australia's Boost Juice Features 700 mg of Martek's life'sDHA(TM) 3Health News:RealAge Challenges and Cheers Smoke-Free Wannabes in 2008 2
... enzyme linked immunosorbent assay ... and semiquantitation of anti-glomerular ... in human serum. The ... can be used as ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
Rheumatoid factor screening...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) IgA isotype in human serum....
Medicine Products: